文献速递糖尿病肥胖与代谢综合征

二甲双胍削弱代谢综合征风险成人运动训练后的血管胰岛素敏感性

Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

这项双盲安慰剂对照试验将代谢综合征风险成人随机分入低或高强度运动联合安慰剂或二甲双胍(2000 mg/d)组干预16周,用高胰岛素正葡萄糖钳夹评估血管胰岛素敏感性。结果显示安慰剂组运动增加血管胰岛素敏感性,而二甲双胍削弱该效应,并减弱空腹血糖、ET-1和TNF-α的改善。

要点

  • 二甲双胍削弱运动训练介导的传导动脉和微血管胰岛素敏感性提升。
  • 二甲双胍减弱运动对空腹血糖、ET-1和TNF-α的改善。
  • 该效应在低强度和高强度运动下均存在。

核心结论

  • 二甲双胍在传导动脉和毛细血管水平削弱运动训练介导的血管胰岛素敏感性增加,并伴随炎症和血糖获益的改变。

研究设计与样本

  • 双盲、安慰剂对照试验,参与者随机分入低强度运动+安慰剂(n=22)、低强度运动+二甲双胍(2000 mg/d,n=21)、高强度运动+安慰剂(n=24)或高强度运动+二甲双胍(n=24)组,干预16周。
  • 治疗前后进行120分钟高胰岛素正葡萄糖钳夹(40 mU/m2/min,90 mg/dL),评估肱动脉血流介导扩张(%FMD)和对比增强超声微血管指标。

主要发现

  • 低强度运动+安慰剂和高强度运动+安慰剂组VO2max增加(均P < .05),而两个二甲双胍组无变化。
  • 仅高强度运动+安慰剂和高强度运动+二甲双胍组体脂减少(均P < .05)。
  • 二甲双胍削弱了低强度运动+安慰剂和高强度运动+安慰剂组中胰岛素刺激的FMDallometric和MBF增加(P < .05)。
  • 与低强度运动+安慰剂和高强度运动+安慰剂组相比,二甲双胍减弱了空腹血糖、ET-1和TNF-α的降低(P < .05)。

临床怎么用

  • 对于代谢综合征风险成人,二甲双胍联合运动训练时需注意其可能削弱运动对血管胰岛素敏感性的改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Metformin is the first-line pharmacotherapy for treating hyperglycemia, and it lowers cardiovascular disease risk. Prior work suggests that metformin can, however, interfere with metabolic adaptations to exercise. To date, no work has tested if metformin (Met) alters exercise training mediated vascular insulin sensitivity, and whether this is exercise intensity dependent. OBJECTIVE: This work aimed to test the hypothesis that Met blunts vascular insulin sensitivity in an intensity-based manner among adults at risk for metabolic syndrome. METHODS: In a double-blind, placebo-controlled trial, participants were randomly assigned to low-intensity exercise plus placebo (∼55% VO2max 5d/wk, LoEx + PL, n = 22) or metformin (2000 mg/d, LoEx + Met, n = 21) and high-intensity exercise plus placebo (∼85% VO2max 5d/wk, HiEx + PL, n = 24) or metformin (HiEx + Met, n = 24) for 16 weeks. A 120-minute euglycemic-hyperinsulinemic clamp (40 mU/m2/min, 90 mg/dL) was conducted pre and post treatment to assess macrovascular insulin sensitivity via brachial artery flow-mediated dilation (%FMD, conduit artery) as well as microvascular insulin sensitivity using contrast-enhanced ultrasound (eg, microvascular blood volume [MBV, perfusion] and microvascular blood flow [MBF]). Fasting and clamp-derived glucose, insulin, inflammatory measures (eg, endothelin-1 [ET-1], tumor necrosis factor α [TNF-α], soluble receptor for advanced glycation end products [sRAGE]), and nitric oxide (nitrite/nitrate) were assessed. Aerobic fitness (maximal oxygen consumption [VO2max]) and body composition (dual-energy x-ray absorptiometry [DXA]) were also analyzed. RESULTS: LoEx + PL and HiEx + PL increased VO2max (both P < .05), while there was no change after LoEx + Met or HiEx + Met. Body fat was reduced following HiEx + PL and HiEx + Met only (both P < .05). Met blunted the increase in insulin-stimulated FMDallometric and MBF seen with LoEx + PL and HiEx + PL (P < .05). Met also attenuated the reductions in fasting glucose, ET-1, and TNF-α compared with LoEx + PL and HiEx + PL (P < .05). CONCLUSION: Met blunts exercise training-mediated increases in vascular insulin sensitivity at the levels of conduit arteries and capillaries, in parallel with altered inflammation and glycemic benefits.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Malin SK, Heiston EM, Battillo DJ, et al. Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome. J Clin Endocrinol Metab. 2026. PMID: 41160096. doi:10.1210/clinem/dgaf551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。